RECALLS AND SAFETY ALERTS NEUROPSYCHIATRIC EVENTS WITH CERTAIN ASTHMA DRUGS
August 10, 2009
FDA has asked the manufacturers of leukotriene-modifying drugs to include a precaution in their labeling about the potential for neuropsychiatric events with these medications. The drugs include Accolate (zafirlukast), Zyflo (zileuton) and Zyflo CR ...
Full Story Below
Rapid Response
Free Case Evaluation
The Help You Need,
When You Need it Most
More from FDA News Directory
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
